Latest article
Novo Nordisk presents trial outcomes of Xultophy for sort 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
Diabetes-prevention program helps addition of years to common lifespan
There is a lot you can do in four years: go from white to black belt in taekwondo, plant a dwarf apple tree and...
Translational analysis ends in promising mixture therapeutic candidate for kind 1 diabetes
Translational research, led by scientists at the La Jolla Institute of Immunology...